- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/785 - Alveolar surfactant peptidesPulmonary surfactant peptides
Patent holdings for IPC class C07K 14/785
Total number of patents in this class: 90
10-year publication summary
4
|
3
|
1
|
17
|
3
|
5
|
0
|
6
|
6
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Chiesi Farmaceutici S.p.A. | 959 |
13 |
Airway Therapeutics, LLC | 6 |
6 |
Children's Hospital Medical Center | 709 |
5 |
Glycotope GmbH | 75 |
4 |
Alphabeta AB | 13 |
3 |
Civitas Therapeutics, Inc. | 29 |
3 |
Discovery Laboratories, Inc. | 19 |
3 |
Windtree Therapeutics, Inc. | 37 |
3 |
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 36 |
3 |
Airway Therapeutics, Inc. | 12 |
3 |
The Arizona Board of Regents on Behalf of the University of Arizona | 2069 |
2 |
Azargen Biotechnologies (Pty) Ltd | 3 |
2 |
Children's Medical Center Corporation | 1828 |
2 |
Ethris GmbH | 99 |
2 |
University of Miami | 833 |
2 |
University of Rochester | 1278 |
2 |
University of Southampton | 447 |
2 |
Glaxosmithkline Biologicals S.A. | 1700 |
1 |
The Trustees of Columbia University in the City of New York | 3524 |
1 |
Kaneka Corporation | 4495 |
1 |
Other owners | 27 |